Alere iFlu A&B
Device
Alere Inc.
Total Payments
$986,357
Transactions
52
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $986,357 | 52 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $986,357 | 52 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Evaluation of the Clinical Performance of the modified Alere I Influenza A&B Test | Alere Inc. | $880,982 | 0 |
| Nasopharyngeal Swab Collection for the Detection of Respiratory Pathogens | Alere Inc. | $52,150 | 0 |
| Evaluation of the Clinical Performance of the BinaxNOW Influenza A&B Card | Alere Inc. | $48,725 | 0 |
| Evaluation of the Clinical Performance of the Alere I Flu 2.0 Test | Alere Inc. | $4,500 | 0 |
Top Doctors Receiving Payments for Alere iFlu A&B
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cleveland, OH | $986,357 | 52 |
Ad
Manufacturing Companies
- Alere Inc. $986,357
Product Information
- Type Device
- Total Payments $986,357
- Total Doctors 0
- Transactions 52
About Alere iFlu A&B
Alere iFlu A&B is a device associated with $986,357 in payments to 0 healthcare providers, recorded across 52 transactions in the CMS Open Payments database. The primary manufacturer is Alere Inc..
Payment data is available from 2017 to 2017. In 2017, $986,357 was paid across 52 transactions to 0 doctors.
The most common payment nature for Alere iFlu A&B is "Unspecified" ($986,357, 100.0% of total).
Alere iFlu A&B is associated with 4 research studies, including "Evaluation of the Clinical Performance of the modified Alere I Influenza A&B Test" ($880,982).